AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 104 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $25,000 | +56.2% | 1,108 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $16,000 | -23.8% | 1,108 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $21,000 | -71.2% | 1,108 | -69.9% | 0.00% | -75.0% |
| Q3 2019 | $73,000 | -6.4% | 3,679 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $78,000 | +4.0% | 3,679 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $75,000 | +7.1% | 3,679 | +4.5% | 0.01% | 0.0% |
| Q4 2018 | $70,000 | +233.3% | 3,522 | +217.9% | 0.01% | +400.0% |
| Q3 2018 | $21,000 | +23.5% | 1,108 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $17,000 | -19.0% | 1,108 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $21,000 | 0.0% | 1,108 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $21,000 | -22.2% | 1,108 | -25.4% | 0.00% | -50.0% |
| Q3 2017 | $27,000 | 0.0% | 1,485 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $27,000 | +22.7% | 1,485 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $22,000 | -18.5% | 1,485 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $27,000 | -3.6% | 1,485 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $28,000 | – | 1,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |